Development of a novel strategy of vaccination against bovine herpesvirus 1 based on a suicide vaccine, which is able to perform only a single cycle of replication after intranasal inoculation. The vaccine combines the high immunogenic potential of a live vaccine and the safety of a killed vaccine.
Fields of science
Topic(s)Data not available
Call for proposalData not available
Funding SchemeRGI - Research grants (individual fellowships)
Universite de Liege
Boulevard De Colonster, 20, B43b
See on map